STOCK TITAN

[Form 4] RESEARCH SOLUTIONS INC Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Research Solutions CEO Roy W. Olivier reported a Form 4 filing on June 28, 2025, disclosing a transaction dated June 20, 2025. The insider, who serves as both Director and CEO & President, surrendered 2,126 shares of Common Stock at a price of $2.69 per share.

The transaction was coded as 'F', indicating shares were surrendered to cover tax obligations related to vested restricted stock. This surrender was specifically approved by the company's Compensation Committee of the Board of Directors.

Following the reported transaction, Olivier maintains direct beneficial ownership of 608,253 shares of Research Solutions common stock. The transaction demonstrates standard executive compensation tax management practices rather than discretionary trading activity.

Il CEO di Research Solutions, Roy W. Olivier, ha comunicato una dichiarazione Form 4 il 28 giugno 2025, riguardante una transazione datata 20 giugno 2025. L'insider, che ricopre i ruoli di Direttore, CEO e Presidente, ha ceduto 2.126 azioni di azioni ordinarie al prezzo di 2,69 $ per azione.

La transazione è stata classificata come 'F', indicando che le azioni sono state cedute per coprire obblighi fiscali relativi a stock restricted maturati. Questa cessione è stata specificamente approvata dal Comitato per la Retribuzione del Consiglio di Amministrazione dell'azienda.

A seguito della transazione comunicata, Olivier mantiene la proprietà beneficiaria diretta di 608.253 azioni ordinarie di Research Solutions. L'operazione riflette pratiche standard di gestione fiscale della retribuzione esecutiva, piuttosto che attività di trading discrezionale.

El CEO de Research Solutions, Roy W. Olivier, informó una presentación Formulario 4 el 28 de junio de 2025, revelando una transacción fechada el 20 de junio de 2025. El insider, que actúa como Director, CEO y Presidente, entregó 2,126 acciones de acciones comunes a un precio de $2.69 por acción.

La transacción fue codificada como 'F', lo que indica que las acciones fueron entregadas para cubrir obligaciones fiscales relacionadas con acciones restringidas que ya habían sido adquiridas. Esta entrega fue aprobada específicamente por el Comité de Compensación de la Junta Directiva de la empresa.

Tras la transacción reportada, Olivier mantiene la propiedad beneficiaria directa de 608,253 acciones comunes de Research Solutions. La operación refleja prácticas estándar de gestión fiscal en compensaciones ejecutivas, en lugar de actividad discrecional de trading.

Research Solutions의 CEO Roy W. Olivier는 2025년 6월 28일 Form 4 신고를 통해 2025년 6월 20일자 거래를 공개했습니다. 이 내부자는 이사 및 CEO 겸 사장으로서 2,126주의 보통주를 주당 $2.69의 가격에 반납했습니다.

이 거래는 'F' 코드로 분류되었으며, 이는 제한 주식이 성취되어 발생한 세금 의무를 충당하기 위해 주식을 반납한 것임을 나타냅니다. 이 반납은 회사 이사회 보상위원회의 특별 승인을 받았습니다.

보고된 거래 이후 Olivier는 Research Solutions 보통주 608,253주의 직접적인 실질 소유권을 유지하고 있습니다. 이 거래는 임원 보상 관련 세금 관리 관행을 보여주며, 임의적인 거래 활동이 아님을 나타냅니다.

Le PDG de Research Solutions, Roy W. Olivier, a déclaré un dépôt Formulaire 4 le 28 juin 2025, révélant une transaction datée du 20 juin 2025. L'initié, qui est à la fois Directeur, PDG et Président, a cédé 2 126 actions ordinaires au prix de 2,69 $ par action.

La transaction a été codée 'F', indiquant que les actions ont été cédées pour couvrir des obligations fiscales liées à des actions restreintes acquises. Cette cession a été spécifiquement approuvée par le Comité de rémunération du conseil d'administration de la société.

À la suite de la transaction déclarée, Olivier conserve la propriété bénéficiaire directe de 608 253 actions ordinaires de Research Solutions. Cette opération illustre des pratiques standard de gestion fiscale des rémunérations exécutives plutôt qu'une activité de trading discrétionnaire.

Research Solutions CEO Roy W. Olivier meldete am 28. Juni 2025 eine Form 4 Einreichung, die eine Transaktion vom 20. Juni 2025 offenlegt. Der Insider, der zugleich Direktor sowie CEO & Präsident ist, gab 2.126 Aktien von Stammaktien zu einem Preis von 2,69 $ pro Aktie ab.

Die Transaktion wurde mit dem Code 'F' gekennzeichnet, was darauf hinweist, dass Aktien zur Deckung von Steuerverpflichtungen im Zusammenhang mit bereits erworbenen Restricted Stocks abgegeben wurden. Diese Abgabe wurde ausdrücklich vom Vergütungsausschuss des Vorstands genehmigt.

Nach der gemeldeten Transaktion hält Olivier weiterhin den direkten wirtschaftlichen Eigentum an 608.253 Aktien von Research Solutions Stammaktien. Die Transaktion zeigt übliche steuerliche Managementpraktiken bei der Vergütung von Führungskräften und keine diskretionären Handelsaktivitäten.

Positive
  • None.
Negative
  • None.

Il CEO di Research Solutions, Roy W. Olivier, ha comunicato una dichiarazione Form 4 il 28 giugno 2025, riguardante una transazione datata 20 giugno 2025. L'insider, che ricopre i ruoli di Direttore, CEO e Presidente, ha ceduto 2.126 azioni di azioni ordinarie al prezzo di 2,69 $ per azione.

La transazione è stata classificata come 'F', indicando che le azioni sono state cedute per coprire obblighi fiscali relativi a stock restricted maturati. Questa cessione è stata specificamente approvata dal Comitato per la Retribuzione del Consiglio di Amministrazione dell'azienda.

A seguito della transazione comunicata, Olivier mantiene la proprietà beneficiaria diretta di 608.253 azioni ordinarie di Research Solutions. L'operazione riflette pratiche standard di gestione fiscale della retribuzione esecutiva, piuttosto che attività di trading discrezionale.

El CEO de Research Solutions, Roy W. Olivier, informó una presentación Formulario 4 el 28 de junio de 2025, revelando una transacción fechada el 20 de junio de 2025. El insider, que actúa como Director, CEO y Presidente, entregó 2,126 acciones de acciones comunes a un precio de $2.69 por acción.

La transacción fue codificada como 'F', lo que indica que las acciones fueron entregadas para cubrir obligaciones fiscales relacionadas con acciones restringidas que ya habían sido adquiridas. Esta entrega fue aprobada específicamente por el Comité de Compensación de la Junta Directiva de la empresa.

Tras la transacción reportada, Olivier mantiene la propiedad beneficiaria directa de 608,253 acciones comunes de Research Solutions. La operación refleja prácticas estándar de gestión fiscal en compensaciones ejecutivas, en lugar de actividad discrecional de trading.

Research Solutions의 CEO Roy W. Olivier는 2025년 6월 28일 Form 4 신고를 통해 2025년 6월 20일자 거래를 공개했습니다. 이 내부자는 이사 및 CEO 겸 사장으로서 2,126주의 보통주를 주당 $2.69의 가격에 반납했습니다.

이 거래는 'F' 코드로 분류되었으며, 이는 제한 주식이 성취되어 발생한 세금 의무를 충당하기 위해 주식을 반납한 것임을 나타냅니다. 이 반납은 회사 이사회 보상위원회의 특별 승인을 받았습니다.

보고된 거래 이후 Olivier는 Research Solutions 보통주 608,253주의 직접적인 실질 소유권을 유지하고 있습니다. 이 거래는 임원 보상 관련 세금 관리 관행을 보여주며, 임의적인 거래 활동이 아님을 나타냅니다.

Le PDG de Research Solutions, Roy W. Olivier, a déclaré un dépôt Formulaire 4 le 28 juin 2025, révélant une transaction datée du 20 juin 2025. L'initié, qui est à la fois Directeur, PDG et Président, a cédé 2 126 actions ordinaires au prix de 2,69 $ par action.

La transaction a été codée 'F', indiquant que les actions ont été cédées pour couvrir des obligations fiscales liées à des actions restreintes acquises. Cette cession a été spécifiquement approuvée par le Comité de rémunération du conseil d'administration de la société.

À la suite de la transaction déclarée, Olivier conserve la propriété bénéficiaire directe de 608 253 actions ordinaires de Research Solutions. Cette opération illustre des pratiques standard de gestion fiscale des rémunérations exécutives plutôt qu'une activité de trading discrétionnaire.

Research Solutions CEO Roy W. Olivier meldete am 28. Juni 2025 eine Form 4 Einreichung, die eine Transaktion vom 20. Juni 2025 offenlegt. Der Insider, der zugleich Direktor sowie CEO & Präsident ist, gab 2.126 Aktien von Stammaktien zu einem Preis von 2,69 $ pro Aktie ab.

Die Transaktion wurde mit dem Code 'F' gekennzeichnet, was darauf hinweist, dass Aktien zur Deckung von Steuerverpflichtungen im Zusammenhang mit bereits erworbenen Restricted Stocks abgegeben wurden. Diese Abgabe wurde ausdrücklich vom Vergütungsausschuss des Vorstands genehmigt.

Nach der gemeldeten Transaktion hält Olivier weiterhin den direkten wirtschaftlichen Eigentum an 608.253 Aktien von Research Solutions Stammaktien. Die Transaktion zeigt übliche steuerliche Managementpraktiken bei der Vergütung von Führungskräften und keine diskretionären Handelsaktivitäten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
OLIVIER ROY W

(Last) (First) (Middle)
C/O RESEARCH SOLUTIONS, INC.

(Street)

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO & President
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/20/2025 F(1) 2,126 D $2.69 608,253 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person surrendered these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors.
/s/ William Nurthen, Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did RSSS CEO Roy Olivier surrender for tax purposes on June 20, 2025?

RSSS CEO Roy Olivier surrendered 2,126 shares at a price of $2.69 per share to cover taxes on vested restricted stock. This transaction was approved by the Compensation Committee of the company's Board of Directors.

How many shares of RSSS does CEO Roy Olivier own after the June 2025 transaction?

Following the reported transaction, CEO Roy Olivier directly owns 608,253 shares of Research Solutions (RSSS) common stock.

What positions does Roy Olivier hold at RSSS according to the Form 4?

According to the Form 4 filing, Roy Olivier serves as both Director and CEO & President of Research Solutions (RSSS).

What type of transaction did RSSS CEO execute in the June 2025 Form 4?

The Form 4 shows a 'Code F' transaction, which indicates the CEO surrendered shares to the company to satisfy tax withholding obligations related to the vesting of restricted stock awards.
Research Solutions Inc

NASDAQ:RSSS

RSSS Rankings

RSSS Latest News

RSSS Latest SEC Filings

RSSS Stock Data

88.61M
26.69M
17.61%
46.03%
0.13%
Software - Application
Services-business Services, Nec
Link
United States
HENDERSON